Genus News and Activities

Presence

Genus is a biotechnology company that specializes in genetic improvement of animals to provide pork, dairy, and beef. It develops porcine, dairy, and beef cattle breeding technology with the application of gene editing and other biotechnologies, catering to farmers globally.

Genus products and services overview:

Porcine genetics
Dairy cattle genetics
Beef cattle genetics
Biotechnology services

2024 Revenue: Approximately $600 million

Employees: 2,800

Genus is one of the...

Genus is a company listed under the stock ticker GNS (GB).

Genus has a direct presence in 9 countries.

Genus has 9 subsidiaries including ABS Africa, ABS Australia and ABS Canada.

They are in:

Farming80%
Biotechnology20%

Executives

View the org chart displaying its 112 main executives

Most searched biographies at Genus

Popular executive movements at Genus

Andy Russell will join the company as Chief Financial Officer on Aug. 1, 2025 (posted on March 13 2025).
Sarah Dodd who was Human Resources Business Partner, becomes Human Resources Manager, United Kingdom (posted on March 13 2025).
Alison Henriksen, Chief Financial Officer and Director, will retire on Jul. 31, 2025 (posted on October 22 2024).

Create your alert
to follow the executive moves at Genus.